SEARCH

SEARCH BY CITATION

References

  • 1
    Bennet FJ (1989) The dilemma of essential drugs in primary health care. Social Science and Medicine 28, 10851090.
  • 2
    Berg E (1992) Rethinking technical co-operation. UNDP-Report. United Nations, New York.
  • 3
    BMZ (German Federal Ministry for Economic Co-operation and Development) (1991) Main report on evaluation of the development program ‘Improvement of the Primary Health Care System’ in the provinces Littoral, South West and North West in Cameroun. Bonn, Germany.
  • 4
    Bol DHH, Polderman J & Schönhals C (1989) Country Evaluation Nigeria. WHO Essential Drugs Programme, p. 14.
  • 5
    Brunet-Jailly J, Diarra K, Keita M & von Massow F (1994) Etude sur la réorganisation des systèmes d'approvisionnement en médicaments essentiels dans la région de Mopti. (Project report) Deutsche Gesellschaft für Technische Zusammenarbeit, Eschborn.
  • 6
    Buyck B (1991) The Bank's Use of Technical Assistance for Institutional Development. World Bank, Washington.
  • 7
    Carrin G (1987) Community financing of drugs in sub-Saharan Africa. International Journal of Health Planning and Management 2, 125145.
  • 8
    Cheka C & Schmidt-Ehry B (1991) Community health co-financing and management experiences of GTZ (PHC) Cameroun. Deutsche Gesellschaft für Technische Zusammenarbeit, Eschborn.
  • 9
    De Ferranti D (1985) Paying for health services in developing countries: a call for realism. World Health Forum 6, 99105.
  • 10
    Foster S (1991) Supply and use of essential drugs in sub-Saharan Africa: some issues and possible solutions. Social Science and Medicine 32, 12011218.
  • 11
    Foster S, Drager N (1988) How community drug sales schemes may succeed. World Health Forum 9, 200206.
  • 12
    Ghogomu AN, Schmidt-Ehry B, Tata H & Meloni R (1996) The impact of socio-economic crisis on the reorganized health system in the North West Province of Cameroun. Deutsche Gesellschaft für Technische Zusammenarbeit, Eschborn.
  • 13
    Got H & von Massow F (1992) Study on: Interventions of the EEC within the health sector in Cameroun. Deutsche Gesellschaft für Technische Zusammenarbeit, Eschborn.
  • 14
    Griffith A (1987) Drug supply and use in developing countries: problems and policies. In Health, nutrition, and economic crises: approaches to policy in the third world (eds. DE Bell & MR Reich), Auburn House, Dover, MA, pp. 349–377.
  • 15
    Habimana G (1997) Proposal for action by AFDRAN based on the experience of a pharmacist responsible for the implementation of the drug programme under the World Bank structural adjustment programme in Rwanda before 1994. Consultation of African drug quality assurance and drug regulation experts, Harare, 8–12 September 1997.
  • 16
    Hardon A, Le Grand A (1993) Pharmaceuticals in communities: practices, public health consequences and intervention strategies. Royal Tropical Institute Amsterdam Bulletin 330, 139.
  • 17
    Huss R (1996) Pharmaceutical consumers' co-operatives – the third path. World Hospitals 31, 1315.
  • 18
    Jaycox EVK (1993) Capacity Building: The Missing Link in African Development. World Bank, Washington.
  • 19
    Kanji N (1989) Charging for drugs in Africa: UNICEF's ‘Bamako Initiative’. Health Policy and Planning 4, 110120.
  • 20
    Kuper M (1991) Report on the consultancy in the project ‘Primary Health Care Drug Programme in NW/SW/LT Provinces in Cameroun’. Deutsche Gesellschaft für Technische Zusammenarbeit, Eschborn.
  • 21
    Kuper M (1993) Report on the consultancy in the project ‘GTZ-Primary Health Care Programmes in Cameroun’ Deutsche Gesellschaft für Technische Zusammenarbeit, Eschborn.
  • 22
    Litvak JI, Bodart C (1993) User fees plus quality equals improved access to health care: results of a field experiment in Cameroun. Social Science and Medicine 37, 369383.
  • 23
    Litvak JI, Shepard DS, Quick JD (1989) Setting the price of essential drugs: necessity and affordability. Lancet 334, 376379.
  • 24
    McPake B, Hanson K, Mills A (1993) Community financing of health care in Africa: An evaluation of the Bamako Initiative. Social Science and Medicine 36, 13831395.
  • 25
    Mills A, Walker GJA (1983) Drugs for the poor of the third world: consumption and distribution. Journal of Tropical Medicine and Hygiene 86, 139145.
  • 26
    Monekosso GL, Cheka CN, Ghogomu AN, Schmidt-Ehry B (1996) Possible roles for the provincial special fund for health in the definition and functioning of health districts in Cameroun. Journal of Camerounais de Médecine 5, 2628.
  • 27
    MSH (1982) Managing drug supply. Management Sciences for Health, Boston.
  • 28
    Nchinda TC (1978) The propharmacy as a means of meeting chronic drug shortages in rural health centres in rural African communities. Tropical Doctor 8, 226228.
  • 29
    Oben B (1989) Report on the PHC Drug Distribution Program, carried out for the Delegation of Health, Buea, SW Province of Cameroun. Deutsche Gesellschaft für Technische Zusammenarbeit, Eschborn.
  • 30
    Pan-American Health Organization (1988) Essential drugs revolving fund for Central America and Panama. Bulletin of the Paho22, 313–316.
  • 31
    Patel M (1986) An economic evaluation of ‘Health for All’. Health Policy and Planning 1, 3747.
  • 32
    Sauerborn R, Bodart C, Essomba RO (1995) Recovery of recurrent health service costs through provincial health funds in Cameroun. Social Science and Medicine 40, 17311739.
  • 33
    Schrettenbrunner A, Harpham T (1993) A different approach to evaluating PHC projects in developing countries: how acceptable is it to aid agencies? Health Policy and Planning 8, 128135.
  • 34
    Senant P, Epaillard J-P, Rasoloarison C & Kirsch-Woik T (1997) Die Dezentralisierung des Gesundheitssystems in Madagaskar: welches Verwaltungsmodell für die Gesundheitszentren? Projet ‘renforcement de la santé de base à Mahajanga’– Deutsche Gesellschaft für Technische Zusammenarbeit, Eschborn.
  • 35
    Speight ANP (1975) Cost-effectiveness and drug therapy. Tropical Doctor 5, 8992.
  • 36
    Van der Geest S (1982) The efficiency of inefficiency: medicine distribution in south Cameroun. Social Science and Medicine 16, 21452153.
  • 37
    Van der Geest S (1983) Propharmacies: A problematic means of drug distribution in rural Cameroun. Tropical Doctor 13, 911.
  • 38
    Velasques G (1989) Médicaments et financement des systèmes de santé dans les pays du Tiers Monde ‘le recouvrement des couts’: un concept a revoi. Revue Tiers Monde 30, 455463.
  • 39
    von Massow F (1984) Progress report of the project ‘Establishment of a drug supply system for the Southern Sudan. Deutsche Gesellschaft für Technische Zusammenarbeit, Eschborn.
  • 40
    von Massow F (1985) Feasibility Study on the establishment of a drug supply system for the NW- and SW-Province in Cameroun, carried out for the Deutsche Gesellschaft für Technische Zusammenarbeit. GTZ, Eschborn.
  • 41
    von Massow F (1995) Final report ‘Establishment of a community based PHC drug supply system’ for the project ‘Primary Health Care in Juba, Sudan’. Deutsche Gesellschaft für Technische Zusammenarbeit, Eschborn.
  • 42
    Waddington C, Panza A (1991) Ten questions to ask about revolving funds. Tropical Doctor 21, 5053.
  • 43
    World Bank (1992) Effective implementation: Key to development impact. World Bank, Washington.
  • 44
    WHO (1991) Drug supply by ration kits: report of an evaluation. WHO/DAP/91.2, Geneva.
  • 45
    World Bank (1994a) Pour une meilleure santé en Afrique. World Bank, Washington. p. 95ff.
  • 46
    World Bank (1994b) Cameroun: Diversité, croissance, et réduction de la pauvreté. World Bank, Washington.